FM
HALO icon

Foster & Motley’s Halozyme HALO Stock Holding History

Foster & Motley’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
25,501
+1,451
+6% +$98.9K 0.09% 170
2026
Q1 		$1.55M Buy
24,050
+1,218
+5% +$85.9K 0.08% 192
2025
Q4 		$1.54M Sell
22,832
-377
-2% -$25.4K 0.08% 187
2025
Q3 		$1.7M Sell
23,209
-320
-1% -$21.3K 0.09% 186
2025
Q2 		$1.22M Sell
23,529
-377
-2% -$21.5K 0.07% 212
2025
Q1 		$1.52M Buy
23,906
+626
+3% +$36.4K 0.1% 183
2024
Q4 		$1.11M Buy
23,280
+12,630
+119% +$648K 0.07% 207
2024
Q3 		$609K Buy
+10,650
New +$611K 0.04% 255

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Foster & Motley's HALO Position: Q2 2026 in Review

Foster & Motley increased its Halozyme (HALO) stake by 6% in Q2 2026, buying an estimated $98.9K and bringing the position to 25,501 shares worth $2M. The position accounts for 0.09% of the portfolio, ranked #170.

Foster & Motley first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Foster & Motley held 25,501 shares of Halozyme worth $2M as of Q2 2026.
  • Foster & Motley bought 1,451 Halozyme shares in Q2 2026, an estimated $98.9K.
  • Halozyme made up 0.09% of Foster & Motley's portfolio in Q2 2026, its #170 holding.
  • Foster & Motley first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.